Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study
Background There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagn...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.023643 |
_version_ | 1797859016706097152 |
---|---|
author | Husam Abdel‐Qadir Madison Gunn Iliana C. Lega Andrea Pang Peter C. Austin Sheldon M. Singh Cynthia A. Jackevicius Karen Tu Paul Dorian Douglas S. Lee Dennis T. Ko |
author_facet | Husam Abdel‐Qadir Madison Gunn Iliana C. Lega Andrea Pang Peter C. Austin Sheldon M. Singh Cynthia A. Jackevicius Karen Tu Paul Dorian Douglas S. Lee Dennis T. Ko |
author_sort | Husam Abdel‐Qadir |
collection | DOAJ |
description | Background There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagnosed AF. Methods and Results This was a population‐based cohort study using linked administrative data sets. We studied 37 209 individuals aged ≥66 years diagnosed with AF in Ontario between April 2009 and March 2019, who had diabetes diagnosed 1 to 16 years beforehand. The primary outcome was hospitalization for stroke at 1 year. Cause‐specific hazard regression was used to model the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke. Restricted cubic spline analyses showed increasing hazard ratios (HR) for stroke with longer diabetes duration that plateaued after 10 years and increasing HRs for stroke with HbA1c levels >7%. Relative to patients with <5 years diabetes duration, stroke rates were significantly higher for patients with ≥10 years duration (HR, 1.45; 95% CI, 1.16–1.82; P=0.001), while diabetes duration 5 to <10 years was not significantly different. Relative to glycated hemoglobin 6% to <7%, values ≥8% were associated with higher stroke rates (HR, 1.44; 95% CI, 1.12–1.84; P=0.004), while other HbA1c categories were not significantly different. Conclusions Longer diabetes duration and higher glycated hemoglobin were associated with significantly higher stroke rates in patients with AF and diabetes. Models for stroke risk prediction and preventive care in AF may be improved by considering patients’ diabetes characteristics. |
first_indexed | 2024-04-09T21:22:41Z |
format | Article |
id | doaj.art-6333c89d2e784214a94bfb8c8730560c |
institution | Directory Open Access Journal |
issn | 2047-9980 |
language | English |
last_indexed | 2024-04-09T21:22:41Z |
publishDate | 2022-02-01 |
publisher | Wiley |
record_format | Article |
series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
spelling | doaj.art-6333c89d2e784214a94bfb8c8730560c2023-03-28T04:20:07ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-02-0111410.1161/JAHA.121.023643Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort StudyHusam Abdel‐Qadir0Madison Gunn1Iliana C. Lega2Andrea Pang3Peter C. Austin4Sheldon M. Singh5Cynthia A. Jackevicius6Karen Tu7Paul Dorian8Douglas S. Lee9Dennis T. Ko10Women’s College Hospital Toronto CanadaSchulich School of Medicine Western University London ON CanadaWomen’s College Hospital Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaDepartment of Medicine University of Toronto CanadaUniversity Health Network Toronto CanadaUniversity Health Network Toronto CanadaDepartment of Medicine University of Toronto CanadaUniversity Health Network Toronto CanadaICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto CanadaBackground There are limited data on the association of diabetes duration and glycemic control with stroke risk in atrial fibrillation (AF). Our objective was to study the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke in people with diabetes and newly diagnosed AF. Methods and Results This was a population‐based cohort study using linked administrative data sets. We studied 37 209 individuals aged ≥66 years diagnosed with AF in Ontario between April 2009 and March 2019, who had diabetes diagnosed 1 to 16 years beforehand. The primary outcome was hospitalization for stroke at 1 year. Cause‐specific hazard regression was used to model the association of diabetes duration and glycated hemoglobin (HbA1c) with the rate of stroke. Restricted cubic spline analyses showed increasing hazard ratios (HR) for stroke with longer diabetes duration that plateaued after 10 years and increasing HRs for stroke with HbA1c levels >7%. Relative to patients with <5 years diabetes duration, stroke rates were significantly higher for patients with ≥10 years duration (HR, 1.45; 95% CI, 1.16–1.82; P=0.001), while diabetes duration 5 to <10 years was not significantly different. Relative to glycated hemoglobin 6% to <7%, values ≥8% were associated with higher stroke rates (HR, 1.44; 95% CI, 1.12–1.84; P=0.004), while other HbA1c categories were not significantly different. Conclusions Longer diabetes duration and higher glycated hemoglobin were associated with significantly higher stroke rates in patients with AF and diabetes. Models for stroke risk prediction and preventive care in AF may be improved by considering patients’ diabetes characteristics.https://www.ahajournals.org/doi/10.1161/JAHA.121.023643atrial fibrillationdiabetesdiabetes durationglycated hemoglobinstroke |
spellingShingle | Husam Abdel‐Qadir Madison Gunn Iliana C. Lega Andrea Pang Peter C. Austin Sheldon M. Singh Cynthia A. Jackevicius Karen Tu Paul Dorian Douglas S. Lee Dennis T. Ko Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease atrial fibrillation diabetes diabetes duration glycated hemoglobin stroke |
title | Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study |
title_full | Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study |
title_fullStr | Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study |
title_full_unstemmed | Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study |
title_short | Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study |
title_sort | association of diabetes duration and glycemic control with stroke rate in patients with atrial fibrillation and diabetes a population based cohort study |
topic | atrial fibrillation diabetes diabetes duration glycated hemoglobin stroke |
url | https://www.ahajournals.org/doi/10.1161/JAHA.121.023643 |
work_keys_str_mv | AT husamabdelqadir associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT madisongunn associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT ilianaclega associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT andreapang associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT petercaustin associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT sheldonmsingh associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT cynthiaajackevicius associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT karentu associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT pauldorian associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT douglasslee associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy AT dennistko associationofdiabetesdurationandglycemiccontrolwithstrokerateinpatientswithatrialfibrillationanddiabetesapopulationbasedcohortstudy |